DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactResults

HALEOS LABS LIMITED — Board Meeting Intimation

NSE 9 hrs ago·7 Nov 2026, 7:44 am

Haleos Labs

Haleos Labs Limited has announced that its board of directors will convene on November 11, 2026. The primary purpose of this meeting is to review and approve the company's unaudited financial results for the quarter ended September 2026. This is a standard corporate procedure where the board evaluates the firm's performance before the figures are made public.

For investors, this announcement is a key milestone as it signals that the company is preparing to disclose its operational health. The upcoming results will provide clarity on Haleos Labs' revenue, profitability, and overall financial trajectory for the third quarter of the fiscal year. This data is essential for shareholders to assess the company's current standing and future growth prospects.

Investors should watch for the release of the financial statements following the board's approval. The results will likely reveal the company's performance against market expectations and competitors. Monitoring this release will help investors gauge the management's execution capabilities and the stock's potential direction in the near term.